awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36529630-0F804EAC-86DC-44C7-928B-C39A5FB43F89
Q36529630-0F804EAC-86DC-44C7-928B-C39A5FB43F89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36529630-0F804EAC-86DC-44C7-928B-C39A5FB43F89
An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial.
P2860
Q36529630-0F804EAC-86DC-44C7-928B-C39A5FB43F89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36529630-0F804EAC-86DC-44C7-928B-C39A5FB43F89
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64b91c442e0a956a179d1d48e58c24c4efc88e07
P2860
Costs of treatment affect compliance to specific subcutaneous immunotherapy.